The Role of NCI-H2126 in Lung Adenocarcinoma Models

Lung adenocarcinoma represents the most prevalent form of non-small cell lung cancer (NSCLC), accounting for approximately 40% of all lung cancer cases worldwide. The NCI-H2126 cell line has emerged as a crucial research tool for scientists investigating this aggressive malignancy. Derived from a pleural effusion of a patient with lung adenocarcinoma, this cell line provides researchers with an invaluable model system for understanding tumor biology, drug resistance mechanisms, and therapeutic interventions in lung cancer research.

Key Takeaways
OriginDerived from pleural effusion of lung adenocarcinoma patient
Cancer TypeNon-small cell lung cancer (NSCLC) - Adenocarcinoma subtype
MorphologyEpithelial-like cells with adherent growth pattern
Key ApplicationsDrug screening, biomarker discovery, metastasis research
Genetic FeaturesWell-characterized mutation profile including oncogenic drivers
Research ValueRepresents advanced disease stage and metastatic potential
Culture RequirementsStandard adherent cell culture conditions with appropriate media

Origin and Characteristics of NCI-H2126 Cell Line

The NCI-H2126 cell line was established from the pleural effusion of a lung adenocarcinoma patient, making it particularly valuable for studying advanced-stage disease progression and metastatic behavior. This origin is clinically significant as pleural effusions are common complications in lung adenocarcinoma patients, often indicating advanced disease with poor prognosis. At Cytion, our NCI-H2126 cells maintain the genetic and phenotypic characteristics representative of this aggressive cancer type. The cell line exhibits typical epithelial morphology with strong adherent growth properties, requiring standard culture conditions that can be supported with our comprehensive range of cell culture media and media and reagents. Researchers studying lung adenocarcinoma mechanisms will find this cell line particularly useful when compared to other lung cancer cell lines in our portfolio, as it represents the complex biology of metastatic disease progression.

Non-Small Cell Lung Cancer Classification and Adenocarcinoma Subtype

Non-small cell lung cancer (NSCLC) encompasses approximately 85% of all lung cancer cases, with adenocarcinoma being the most common histological subtype. The NCI-H2126 cell line specifically represents the adenocarcinoma variant, which typically arises in the peripheral regions of the lungs and demonstrates distinct molecular characteristics compared to other NSCLC subtypes like squamous cell carcinoma. At Cytion, we provide researchers with a comprehensive collection of lung cancer cell lines that represent various NSCLC subtypes, allowing for comparative studies across different histological variants. Our NCI-H2126 cells are particularly valuable for adenocarcinoma research due to their authentic representation of this subtype's biological behavior. Researchers can complement their studies with other adenocarcinoma models from our portfolio, including the well-characterized A549 cells and NCI-H1299 cells, to validate findings across multiple adenocarcinoma models and ensure robust experimental conclusions.

Cellular Morphology and Growth Characteristics

The NCI-H2126 cell line exhibits classic epithelial morphology with polygonal cell shapes and tight cell-to-cell contacts, forming characteristic cobblestone-like monolayers when cultured under optimal conditions. These adherent growth patterns are typical of lung adenocarcinoma cells and reflect the epithelial origin of this cancer type. The cells demonstrate strong substrate adhesion and form confluent monolayers that maintain their epithelial characteristics over multiple passages. At Cytion, our NCI-H2126 cells are cultured using appropriate cell culture media that support their epithelial morphology and growth requirements. For optimal cell detachment during passaging, we recommend using our specialized Accutase solution, which provides gentle and effective cell dissociation while maintaining cell viability. Researchers working with epithelial lung cancer models can compare morphological characteristics with other adherent human cells in our collection to study epithelial-to-mesenchymal transition and other morphological changes associated with cancer progression.

Key Research Applications in Cancer Studies

The NCI-H2126 cell line serves as an invaluable tool for multiple research applications, particularly excelling in drug screening assays where researchers can evaluate the efficacy of novel therapeutic compounds against lung adenocarcinoma. Its robust growth characteristics and consistent response patterns make it ideal for high-throughput screening platforms and dose-response studies. In biomarker discovery research, this cell line provides a reliable model for identifying prognostic and predictive markers specific to adenocarcinoma, contributing to personalized medicine approaches. The metastatic origin of NCI-H2126 makes it particularly valuable for studying invasion and metastasis mechanisms, offering insights into how lung adenocarcinoma cells spread to distant sites. At Cytion, our NCI-H2126 cells are quality-assured and can be combined with our comprehensive range of lung cancer cell lines for comparative studies. Researchers can enhance their investigations by utilizing our cell line authentication services to ensure model integrity, and our mycoplasma testing services to maintain contamination-free cultures essential for reliable experimental results.

Genetic Profile and Oncogenic Driver Mutations

The NCI-H2126 cell line possesses a well-characterized genetic profile that includes several key oncogenic driver mutations commonly found in lung adenocarcinoma patients, making it an authentic representation of the molecular landscape of this disease. These genetic alterations include mutations in critical pathways involved in cell cycle regulation, apoptosis resistance, and growth factor signaling, providing researchers with a clinically relevant model for studying targeted therapeutic approaches. The presence of specific driver mutations makes this cell line particularly valuable for investigating precision medicine strategies and understanding mechanisms of drug resistance that frequently emerge in clinical settings. At Cytion, our NCI-H2126 cells are supplied with comprehensive genetic characterization data to support your research applications. To ensure the genetic integrity of your cell cultures, we recommend utilizing our cell line authentication - Human services, which provide STR profiling to confirm cell line identity. Researchers studying oncogenic pathways can complement their work with other genetically characterized lung cancer cell lines from our portfolio to validate findings across different genetic backgrounds and mutation profiles.

NCI-H2126 Cell Line Lung Adenocarcinoma Research Model 1 Origin & Characteristics Lung • Derived from pleural effusion • Advanced-stage disease model • Epithelial morphology • Adherent growth pattern • Metastatic potential • Cobblestone monolayers • Strong substrate adhesion • Maintains epithelial features 2 NSCLC Classification 85% NSCLC • Non-Small Cell Lung Cancer • Adenocarcinoma subtype • Most common NSCLC variant • Peripheral lung origin • Distinct molecular profile • 85% of lung cancers • Epithelial cell origin • Tight cell-to-cell contacts 3 Key Applications Research • Drug screening assays • High-throughput platforms • Biomarker discovery • Metastasis research • Invasion mechanisms • Therapeutic efficacy • Personalized medicine • Dose-response studies 4 Genetic Profile • Well-characterized mutations • Oncogenic driver genes • Cell cycle regulation • Apoptosis resistance • Growth factor signaling • Drug resistance mechanisms • Precision medicine targets • Clinically relevant profile Cytion - Advanced Cell Culture Solutions for Lung Cancer Research

Clinical Relevance and Advanced Disease Modeling

The NCI-H2126 cell line holds exceptional research value as it authentically represents advanced-stage lung adenocarcinoma with significant metastatic potential, making it an ideal model for studying late-stage disease progression and therapeutic resistance mechanisms. Derived from pleural effusion, this cell line captures the biological complexity of metastatic lung cancer, providing researchers with insights into how adenocarcinoma cells adapt and survive in secondary sites. This advanced disease representation is crucial for developing therapeutic strategies that address the challenges of treating metastatic lung cancer, where conventional treatments often fail. The cell line's metastatic characteristics make it particularly valuable for investigating invasion pathways, angiogenesis, and the tumor microenvironment interactions that facilitate cancer spread. At Cytion, our NCI-H2126 cells are maintained under strict quality control standards to preserve their metastatic phenotype and clinical relevance. Researchers can enhance their metastasis studies by combining this model with other advanced-stage cancer models from our cells and cell lines collection, and ensure experimental reliability through our comprehensive cell banking services that maintain consistent cell characteristics across passages.

Optimal Culture Conditions and Media Requirements

The NCI-H2126 cell line thrives under standard adherent cell culture conditions, requiring appropriate media formulations and controlled environmental parameters to maintain optimal growth and preserve its characteristic properties. These cells typically grow well in standard incubator conditions at 37°C with 5% CO2 in a humidified atmosphere, making them accessible for most research laboratories. The adherent nature of NCI-H2126 cells necessitates proper substrate coating and gentle handling during passaging to maintain cell viability and prevent morphological changes. At Cytion, we provide comprehensive support for NCI-H2126 culture with our high-quality NCI-H2126 cells that come with detailed culture protocols. For optimal growth, researchers can utilize our specialized cell culture media formulations, including RPMI 1640 medium which is commonly used for lung cancer cell lines. To ensure long-term storage and maintain cell stocks, our Freeze Medium CM-1 provides reliable cryopreservation, while our Accutase offers gentle cell detachment for routine passaging without compromising cell integrity.

We have detected that you are in a different country or are using a different browser language than currently selected. Would you like to accept the suggested settings?

Close